Introduction {#S1}
============

Asthma is a chronic respiratory disease characterized by partially and/or fully reversible obstruction of the airways with a high prevalence in the pediatric population (ranging from 2.4 to 37.6%) ([@B30]). Clinically, the signs and symptoms of the disease are the presence of wheezing, dyspnea, chest tightness, and dry cough ([@B26]). According to data from the World Health Organization (WHO), 300 million people in the world are asthmatics with a worldwide mortality rate of 250,000 persons/year. Among the children with asthma, around 5--10% of the patients have severe asthma ([@B28]; [@B26]).

Children with severe therapy-resistant asthma (STRA) are those in which the disease remains uncontrolled, even with optimization of clinical management, or if the disease can only be controlled with GINA step 4 or 5 treatment. These patients present recurrent asthma attacks, with visits to emergencies and frequent hospitalizations, limitation to physical activities, and, consequently, a more sedentary lifestyle. Thus, objective measures of assessment are necessary to determine the exercise capacity of these patients ([@B4]; [@B6]).

The cardiopulmonary exercise test (CPET) is considered the gold standard test for the evaluation of physical fitness, evaluating the interaction between cardiovascular, respiratory, and metabolic systems, thus providing essential and complex information on exercise limitation. However, although CPET is considered the gold standard test, its execution implies the use of equipment and software with a high cost, limiting its applicability in clinical practice ([@B13]). Therefore, the evaluation of exercise capacity through simple and low-cost field tests, such as the modified shuttle test (MST), may be an alternative method to measure physical performance in these patients. The MST is an externally paced test with 15 levels and presenting the distance reached in a course of 10 m as its main outcome. Considering that an incremental protocol with increasing speed is used, MST mimics frequently used CPET protocols, leading subjects to levels close to exhaustion ([@B19]).

Although several studies ([@B3]; [@B32]; [@B19]; [@B22]) have shown a good association between maximal oxygen consumption (VO~2~peak) measured during CPET and the distance covered in the MST in adults, little is known for pediatric populations. Evidence suggests differences in both exercise capacity parameters and clinical characteristics of asthma between children and adults ([@B17]; [@B34]). To date, only one recent study ([@B19]) has evaluated the correlation between these variables in a pediatric sample including mild and moderate asthmatics. Moreover, another study with adult severe asthmatics ([@B18]) showed an important MST reliability. However, there is no evidence on the use of the MST as an exercise capacity assessment tool for children and adolescents with STRA. Thus, the objective of this study was to correlate the distance achieved in the MST with peak oxygen uptake (VO~2~peak) measured through CPET in children and adolescents with STRA. Comparisons of the main physiological responses between tests were also performed.

Materials and Methods {#S2}
=====================

A cross-sectional study was performed including 19 patients with a confirmed diagnosis of STRA, aged between 6 and 18 years, who were regularly clinically followed at an asthma outpatient clinic. The diagnosis of asthma and the classification of disease severity followed the criteria of the Global Initiative for Asthma (GINA) ([@B21]) and the American Thoracic Society -- European Respiratory Society (ERS--ATS) Guidelines of severe asthma ([@B6]). Definition of severe asthma for patients aged ≥6 years was: asthma which requires treatment with guidelines suggested medications for GINA steps 4 and 5 asthma (high dose inhaled corticosteroids -- ICS and LABA or leukotriene modifier/theophylline) for the previous year or systemic corticosteroids for ≥50% of the previous year to prevent it from becoming "uncontrolled" or which remains "uncontrolled" despite this therapy. Patients with osteoarticular and musculoskeletal abnormalities or unable to perform at least one of the tests were excluded. Children and adolescents were also not recruited to the study during asthma exacerbation but could be later recruited at a time of clinical stability. Clinical stability was defined as the absence of severe exacerbation in the preceding month prior to inclusion, hospital admission within the last 3 months, and/or an admission involving intensive care and intubation within the last year.

The study was approved by the Research Ethics Committee of the University under the number 47845415.4.0000.5336. All parents and/or legal guardians signed the Informed Consent Form and the participants signed an Assent Form. Data collection was performed from March 2016 to April 2018 at the Laboratory of Pediatric Physical Activity (Infant Center -- PUCRS).

Parents and/or legal guardians answered the disease control questionnaire (GINA) and after subjects underwent an anthropometric evaluation (weight and height) and a spirometric test. Afterward, the exercise capacity evaluation was performed (MST and CPET). Exercise tests were performed randomly in two consecutive visits (approximately 15 days apart). Both evaluations were performed by three trained researchers with the supervision of one experienced exercise capacity investigator.

Disease Control {#S2.SS1}
---------------

Disease control was assessed using the GINA questionnaire, which is an instrument composed of five questions on symptoms related to the last 4 weeks previous to the interview. This questionnaire provides as final result the categorization of disease control in: controlled asthma (negative answer for all four questions), partially controlled (one to two questions), or uncontrolled (three to four positive answer to questions) ([@B11]).

Anthropometric Data {#S2.SS2}
-------------------

The anthropometric evaluation was performed by measuring the weight and height in duplicate. The weight measurement was performed in orthostasis, with a minimum of clothing and without footwear, using a digital scale (G-tech, Glass 1 FW, Rio de Janeiro, Brazil) previously calibrated with 100 g precision. The height was obtained through a portable stadiometer (AlturaExata, TBW, São Paulo, Brazil) with a precision of 1 mm, with participants barefoot, feet parallel, ankles joined, and arms extended along the body. From these measurements, the body mass index (BMI) was calculated \[weight (kg)/height^2^ (m)\] and expressed as absolute values and *z*-score, corrected for age ([@B11]).

Lung Function {#S2.SS3}
-------------

Spirometry was performed following the recommendations of the ATS--ERS ([@B23]). The test was performed with patients in orthostatic position, without the use of a nasal clip, using the KOKO spirometer (Louisville, CO, United States). The spirometric parameters evaluated included forced vital capacity (FVC), forced expiratory volume in the first second (FEV~1~), and forced expiratory flow between 25 and 75% of vital capacity (FEF~25--75%~). Data were expressed as *z*-score based on an international reference equation ([@B25]).

Cardiopulmonary Exercise Testing {#S2.SS4}
--------------------------------

The test was performed following the recommendations of the American Thoracic Society and American College of Chest Physicians ([@B31]). The evaluation was performed in a computerized system (Aerograph, AeroSport^®^, United States), coupled to a gas analyzer (VO2000, MedGraphics^®^, United States) using an ergometric treadmill (KT-10400, Inbramed^®^, Brazil). The variables collected during the test included VO~2~peak, carbon dioxide production (VCO~2~), maximal ventilation (V~*E*~), respiratory exchange ratio (RER), ventilatory equivalent for oxygen consumption (V~*E*~/VO~2~) and for carbon dioxide production (V~*E*~/VCO~2~), and maximum heart rate (HRmax). The HRmax was obtained through a HR sensor (Polar H10, Bethpage, NY, United States) directly connected to the gas analysis system, using the highest value that an individual could reach in a maximum effort to the point of exhaustion. The final VO~2~peak results were also normalized using percentiles ([@B12]).

The test was performed using a ramp protocol adapted from a previous study ([@B1]). Participants were asked to walk for 2 min to adapt to the treadmill, with a speed of 3 km/h and no inclination. After that, there were increments in the speed of 0.5 km/h every minute, with a fixed slope of 3% until the test was finished ([@B1]). All patients were encouraged to keep pace until exhaustion or the onset of signs and/or limiting symptoms (dyspnea, leg pain, and/or dizziness). In order to consider the test as maximum, at least three of the following criteria should be observed: exhaustion or inability to maintain the required speed, RER \>1.0, HRmax \>85% of the HR estimated (208--0.7 × age) and the presence of a plateau for VO~2~ ([@B27]; [@B1]). The criteria used to define a plateau was an increase in VO~2~ of \<2 mL kg^--1^ min^--1^ during the last minute of test in spite of increasing exercise intensity. At the beginning and the end of the test, data on HR and pulse oxygen saturation (SpO~2~) were collected through a HR sensor (Polar H10, Bethpage, NY, United States) and a pulse oximeter (Nonin^®^, Minneapolis, United States), respectively. Subjective perception of dyspnea and leg fatigue was evaluated using the Modified Borg Scale. HR and SpO~2~ were monitored throughout the CPET protocol.

Modified Shuttle Test {#S2.SS5}
---------------------

Modified shuttle test was performed as described by [@B3]. Patients were familiarized with the test in a previous appointment. The modified test has 15 levels and patients should walk/run with increasing speeds, in a course of 10 m delimited by two cones that must be circumvented by the patient. An audio signal is an integral part of the test and represents the level change, as well as the increase of the patient's speed during the test. The test protocol initiated with an average velocity of 0.5 m/s (level 1), followed by an increment of 0.17 m/s at each subsequent level. The patients were followed by a physiotherapist during the first minute in order to adapt to the rhythm of the audio signal. At the beginning of each level, a standardized verbal incentive was offered. The test was completed when participants stated that they were unable to continue the test, lost the rhythm of the audio signal for two consecutive times, or reached the maximum distance of 1500 m.

Before the start of the test and immediately at the end, HR and SpO~2~ (Nonin^®^, Minneapolis, United States) and the modified BORG score for dyspnea and leg fatigue were measured. The distance achieved was calculated by counting the total number of shuttles at the end of the test and expressed in meters. Also, data obtained in the test were normalized using a national reference equation ([@B10]).

Statistical Analysis {#S2.SS6}
--------------------

The distribution of variables was evaluated using the Shapiro--Wilk test. Symmetric variables were presented as mean and standard deviation and asymmetric variables using median and the interquartile range. Categorical variables were presented in absolute and relative frequency. The delta of the HRmax, HRmax%, and Borg for dyspnea and leg fatigue in both CPET and MST was performed by subtracting peak exercise from resting values. Comparisons between MST and CPET variables were performed with Student's *t*-test for paired samples. Bland--Altman plots were used to demonstrate HRmax and HRmax% agreement between the MST and CPET. Correlations were assessed using a Pearson linear correlation test. All analyses and data processing were performed in SPSS version 18.0 (SPSS Inc., United States). In all cases, the level of significance adopted was *p* \< 0.05.

Results {#S3}
=======

Twenty-one patients with STRA were recruited, but two were unable to perform tests adequately. Thus, 19 patients with STRA (63% female), mean age of 11.5 years, were included. Only seven patients (36.8%) presented with controlled asthma. The mean (*z*-score) FEV~1~ was −0.66 and FVC 0.12, demonstrating values within the limits of normality. The characteristics of the sample are presented in [Table 1](#T1){ref-type="table"}.

###### 

Characterization of the study sample.

  **Variables evaluated**           **Girls (*n* = 10)**   **Boys (*n* = 9)**   **Total (*n* = 19)**
  --------------------------------- ---------------------- -------------------- ----------------------
  **Demographic characteristics**                                               
  Age (years)                       12.2 ± 2.5             10.6 ± 1.8           11.5 ± 2.5
  **Anthropometry**                                                             
  Height (cm)                       145.3 ± 12.2           144.1 ± 11.9         144.7 ± 12.5
  Weight (kg)                       45.0 ± 10.4            44.4 ± 14.0          44.7 ± 12.6
  BMI (absolute)                    21.1 ± 3.7             21.5 ± 7.8           21.3 ± 6.2
  (*z*-score)                       0.6 ± 1.0              0.7 ± 1.0            0.6 ± 1.1
  **Disease control, *n* (%)**                                                  
  Controlled                        1 (10.0)               5 (55.5)             6 (31.6)
  Partially controlled              5 (50.0)               1 (11.1)             6 (31.6)
  Uncontrolled                      4 (40.0)               3 (33.3)             7 (36.8)
  **Lung function**                                                             
  FEV~1~ (absolute)                 2.2 ± 0.5              1.8 ± 0.4            2.0 ± 0.5
  (*z*-score)                       −0.1 ± 1.7             −1.3 ± 1.3           −0.6 ± 1.7
  FVC (absolute)                    2.6 ± 0.6              2.5 ± 0.5            2.6 ± 0.6
  (*z*-score)                       0.3 ± 1.4              −0.1 ± 1.0           0.1 ± 1.3
  VEF~1~/CVF (absolute)             0.8 ± 0.0              0.7 ± 0.1            0.8 ± 0.1
  FEF~25--75%~ (absolute)           2.7 ± 1.2              1.6 ± 0.7            2.2 ± 1.2
  (*z*-score)                       −0.3 ± 1.8             −1.9 ± 1.5           −1.1 ± 1.9

BMI, body mass index; FEV

1

, forced expiratory volume in 1 s; FVC, forced vital capacity; FEF

25

--

75

\%

, forced expiratory flow between 25 and 75% of vital capacity. Values expressed as mean ± standard deviation, except for the control variables of the disease and sex (absolute and relative frequency).

The mean level achieved during the MST was 11.1 ± 1.7 and the average distance reached was 693.8 ± 293.3 m (92.2% of predicted). Regarding variables evaluated on CPET, the mean VO~2~peak was 34.6 ± 7.9 mL kg^--1^ min^--1^, V~*E*~ was 39.6 ± 11.5 L min^--1^ and the median VO~2~peak was found at the 25th percentile (3.5--50). The mean HRmax (bpm) achieved was 180.8 ± 12.1 for the MST and 187.6 ± 9.3 for CPET, whereas the mean HRmax as a percentage of predicted (HRmax%) was 90.7 ± 6.5 for the MST and 93.8 ± 4.5 for CPET. A mean difference of only 6 bpm was found for HRmax (*p* = 0.06) and of 3% for HRmax% (*p* = 0.08) between the tests. A significant decrease in the final SpO~2~ and Borg for dyspnea was found when CPET was compared to the MST ([Table 2](#T2){ref-type="table"}).

###### 

Resting characteristics and physiological responses to exercise testing.

  **Variables evaluated**            **MST**          **CPET**         ***p*-value**
  ---------------------------------- ---------------- ---------------- ---------------
  **Resting**                                                          
  Heart rate (beats/min)             87.9 ± 16.1      89.4 ± 13.6      0.53
  SpO~2~ (%)                         98.3 ± 0.83      98.1 ± 1.5       0.49
  Borg dyspnea                       0.0 (0.0--0.0)   0.0 (0.0--0.2)   0.59
  Borg leg fatigue                   0.0 (0.0--0.5)   0.0 (0.0--1.0)   0.29
  **Physiological responses**                                          
  MST level                          11.1 ± 1.7       --               --
  MST distance (m)                   693.8 ± 293.3    --               --
  MST (%)                            92.2 ± 19.2      --               
  VO~2~ peak (mL kg^--1^ min^--1^)   --               34.6 ± 7.9       --
  VO~2~ percentile^\#^               --               25 (3.5--50)     --
  V~E~ peak (L min^--1^)             --               39.6 ± 11.5      --
  V~E~/VO~2~ peak (L min^--1^)       --               23.5 ± 1.7       --
  V~E~/VCO~2~ peak (L min^--1^)      --               23.2 ± 1.7       --
  RER                                --               1.1 ± 0.06       --
  Max heart rate (beats min^--1^)    180.8 ± 12.1     187.6 ± 9.3      0.06
  Max heart rate (% predicted)       90.7 ± 6.5       93.8 ± 4.5       0.08
  End SpO~2~ (%)                     98.0 ± 1.4       95.6 ± 2.6       \<0.01^∗^
  End Borg dyspnea                   4.0 (2.0--5.0)   2.0 (1.0--4.0)   0.01^∗^
  End Borg leg fatigue               2.0 (1.0--5.0)   3.0 (2.0--5.0)   0.62

MST, modified shuttle test; CPET, cardiopulmonary exercise testing; SpO
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, pulse oxygen saturation; VO
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, maximal oxygen uptake; V
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, minute ventilation; V
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, ventilatory equivalent ratio for carbon dioxide production; RER, respiratory exchange ratio. Values expressed as mean ± standard deviation and \# median and interquartile range.

∗

indicate significant differences (

p

\< 0.05).

We have also evaluated differences between peak exercise and resting values (delta) for both tests and no significant differences were found for HRmax, HRmax%, Borg for dyspnea, and Borg for leg fatigue, when MST and CPET were compared ([Figure 1](#F1){ref-type="fig"}). In addition, the Bland--Altman plot shows the agreement of HRmax and HRmax% between the MST and CPET ([Figure 2](#F2){ref-type="fig"}).

![Comparison of the difference (delta) between peak and resting values (bpm) of **(A)** maximum heart rate (HRmax), **(B)** percentage of HRmax and subjective perception of **(C)** dyspnea and **(D)** leg fatigue.](fphys-10-01245-g001){#F1}

![Bland--Altman plot showing individual differences between **(A)** maximum heart rate (HRmax) and **(B)** percent of maximum heart rate (HRmax%) during CPET *versus* the MST. The solid line indicates the mean difference between paired measurements and the dotted lines indicate the 95% limits of agreement.](fphys-10-01245-g002){#F2}

A strong significant correlation (*r* = 0.79; *p* = 0.001) was found between VO~2~peak and the distance achieved in the MST. However, there were no correlations between the MST and both BMI (*r* = −0.14; *p* = 0.564) and FEV~1~ (*r* = −0.02; *p* = 0.917) ([Figure 3](#F3){ref-type="fig"}).

![Correlation between the distance achieved in the modified shuttle test (MST) and **(A)** peak oxygen consumption (VO~2~peak) measured during cardiopulmonary exercise testing (CPET), **(B)** body mass index (BMI), and **(C)** forced expiratory volume in the first second (FEV1).](fphys-10-01245-g003){#F3}

Discussion {#S4}
==========

The results of the present study demonstrated that the MST distance correlates strongly with maximal oxygen uptake measured through CPET in children and adolescents with STRA. In addition, a similar response between tests was demonstrated for HRmax. We believe this is the first study to use the MST for the evaluation of exercise capacity in pediatric STRA patients. Considering that the test is relatively easy-to-perform, safe, and showed an important correlation with CPET, it may be considered as an alternative to evaluate exercise capacity in this population.

Although the benefits of physical exercise are well known, including positive cardiovascular and musculoskeletal effects, quality of life improvement, and better disease control ([@B7]), some studies ([@B24]; [@B7]; [@B14]) demonstrate that adult patients with STRA present significant impairment of physical activity levels. In our study, VO~2~ was reduced when evaluated in both CPET \[six patients (31.6%) with the percentile for VO~2~ \< 5\] and MST \[six patients (31.6%) showing values \< 80% of predicted\], suggesting a compromised exercise capacity. The reduction of physical performance in asthmatics could be attributed to the degree of airway obstruction, the occurrence of exercise-induced bronchoconstriction (EIB), decreased respiratory capacity, and a greater sensation of dyspnea ([@B8]). Thus, the early evaluation of exercise capacity is important, showing an objective information to the patient in order to indicate aerobic training programs, as it is already known that inactive youths tend to become sedentary adults ([@B20]).

Cardiopulmonary exercise test is considered the gold standard for assessing physical fitness. However, this method requires costly equipment, specialized training, and is not always available in clinical practice ([@B29]), especially in developing countries. Thus, it is often necessary to determine exercise capacity using field tests and the MST is considered a simple, externally paced, and incremental (progressive increase of velocity) test ([@B19]). Several studies ([@B8]; [@B18]; [@B19]; [@B33]) have demonstrated good correlations between the distance achieved in the MST and the VO~2~ obtained during CPET, both in respiratory diseases and in other clinical conditions. Recently, one study ([@B19]) showed a strong correlation between the MST and VO~2~ (87% prediction power) in children and adolescents with mild/moderate asthma. These results are similar to ours, considering that we have demonstrated a strong correlation between the MST distance and the VO~2~peak measured on CPET. To the best of our knowledge, this is the first study to correlate the distance achieved in the MST with VO~2~peak in children and adolescents with STRA. Our results corroborate previous research showing a good agreement between CPET and the MST, both in pediatric samples ([@B19]) and in the adult population ([@B8]; [@B18]).

A previous study from our group ([@B9]) showed a negative correlation between nutritional status and MST distance in obese children and adolescents with no respiratory disease. Increased nutritional status leads to an extra body demand to be transferred during daily tasks and to the tendency of subjects to become even more inactive ([@B2]; [@B5]). However, present results demonstrated no correlation between BMI and distance achieved in the MST. Although high BMI is commonly seen in adults with asthma ([@B8]; [@B22]) and may influence exercise capacity, only one previous study demonstrated the deleterious influence of nutritional status on physical performance in asthmatic children ([@B24]). In addition, the lung function showed no correlations with the MST. It is possible that this finding is related to the fact that most patients presented normal lung function.

Although HRmax was slightly higher on CPET, no significant differences were found, as well as mean values of HRmax obtained in both tests were \>180 bpm, indicating a maximum effort level for both tests. These results are in agreement with the study of [@B15], which suggests using 180 bpm as a cut-off value for HRmax in children and adolescents. Also, the findings of the present study confirm a similar HR physiological response between the MST and CPET for children and adolescents with STRA. The mean HRmax difference between tests was only 6 bpm, below that found (13 and 16 bpm) by other studies ([@B32]; [@B19]). Regarding SpO~2~, lower values were measured on CPET compared to the MST. However, as values are within a range of normality, we believe this finding is not clinically relevant. As for the subjective sensation of dyspnea (Borg), there is evidence ([@B32]) showing a greater sensation in the MST compared to CPET, which is in agreement with our results. It is also interesting to note that low scores of dyspnea were found at peak for both tests. Although there are no current explanations available, studies ([@B19]; [@B22]) have also reported low levels of dyspnea evaluated through the Borg scale during maximum tests in asthmatic patients. Nevertheless, these differences should be interpreted with caution, considering that the Borg subjective scale does not present adequate sensitivity for children under the age of 9 years ([@B16]).

Finally, the small number of patients and the impossibility of directly measuring gases during the MST were limitations of our study. Portable expiratory gas analysis was not performed during the MST to assess whether there was the same linear increase in oxygen uptake and VO~2~peak as achieved in CPET. However, our study showed that there was a strong correlation between the MST distance and VO~2~peak on CPET, as well as in clinical practice the outcome measure for the MST is the distance covered by the individual. In addition, given that STRA in children and adolescents is an uncommon clinical phenotype (around 1% of asthmatics), our sample size and power seems adequate for this type of study ([@B8]; [@B18]). In addition, although a maximal response was obtained, it is possible that learning effects may have influenced results, as only one MST was performed.

Conclusion {#S5}
==========

In conclusion, the results of our study demonstrate that the distance achieved in the MST correlates with VO~2~peak measured through CPET in children and adolescents with STRA. In addition, the main physiological variable responses were similar between both tests. Our results provide additional data for the use of the MST to assess exercise capacity in children and adolescents with STRA.
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